Cargando…
3D bioprinted breast tumor-stroma models for pre-clinical drug testing
The use of three-dimensional (3D) bioprinting has been proposed for the reproducible production of 3D disease models that can be used for high-throughput drug testing and personalized medicine. However, most such models insufficiently reproduce the features and environment of real tumors. We report...
Autores principales: | González-Callejo, Patricia, Vázquez-Aristizabal, Paula, García-Astrain, Clara, Jimenez de Aberasturi, Dorleta, Henriksen-Lacey, Malou, Izeta, Ander, Liz-Marzán, Luis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622882/ https://www.ncbi.nlm.nih.gov/pubmed/37928251 http://dx.doi.org/10.1016/j.mtbio.2023.100826 |
Ejemplares similares
-
Trends in Tissue Bioprinting, Cell-Laden Bioink Formulation,
and Cell Tracking
por: Vázquez-Aristizabal, Paula, et al.
Publicado: (2022) -
Shielded Silver Nanorods for Bioapplications
por: Zhuo, Xiaolu, et al.
Publicado: (2020) -
Inulin coated plasmonic gold nanoparticles as a tumor-selective tool for cancer therapy
por: Li Volsi, Anna, et al.
Publicado: (2016) -
SERS
and Fluorescence-Active Multimodal Tessellated
Scaffolds for Three-Dimensional Bioimaging
por: Lenzi, Elisa, et al.
Publicado: (2022) -
Combination of Live Cell Surface-Enhanced Raman Scattering
Imaging with Chemometrics to Study Intracellular Nanoparticle Dynamics
por: Lenzi, Elisa, et al.
Publicado: (2022)